Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds and compositions for modulating EGFR Activity

Compounds and compositions for modulating EGFR Activity

US Patent 9440957 · Granted Sep 13, 2016

Estimated economic value: $24,423,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted quinazoline compounds and methods of use thereof2025
Identification, characterization, and quantitation of CRISPR-introduced double-s2025
Substituted piperazines as inhibitors of KRAS G12C2025
Substituted quinazolines as inhibitors of KRAS G12C2024
Benzimidazole derivatives, and pharmaceutical compositions and methods of use th2023
Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment o2023
Benzimidazoles for use in the treatment of cancer and inflammatory diseases2022
Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment o2022
Aza-indazole compounds for use in tendon and/or ligament injuries2021
N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their use in the treatment 2021
N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their use in the treatment 2021
2-substituted quinazoline compounds comprising a substituted heterocyclic group 2021